市场调查报告书
商品编码
1451865
足下垂植入物市场报告(按产品(功能性电刺激器、内固定装置)、最终用户(医院、安宁疗护中心、骨科中心等)和地区)2024-2032Foot Drop Implants Market Report by Product (Functional Electrical Stimulators, Internal Fixation Devices), End User (Hospitals, Palliative Care Centers, Orthopedic Centers, and Others), and Region 2024-2032 |
2023年,全球足下垂植入物市场规模达到40亿美元。展望未来, IMARC Group预计到2032年市场规模将达到72亿美元,2024-2032年复合年增长率(CAGR)为6.46%。足下垂和神经系统疾病盛行率的上升、老年人口的扩大、对个人化治疗解决方案的需求不断增加以及植入物设计和材料的技术进步是推动市场的一些关键因素。
足下垂是指一种以前脚下垂或抬起脚前部困难为特征的神经系统疾病。它通常是由于腓总神经受损、控制脚踝和足部运动的肌肉无力或瘫痪,或中风、多发性硬化症和脑性麻痹等损伤和病症而发生。它可能导致正常行走困难或偏离,并且通常与步态和背屈等症状有关。足下垂植入物是一种医疗设备,旨在透过更换或加固受损部件来减少这种情况造成的功能限制。它们为脚踝和足部提供稳定性和支撑,使患者能够重新获得活动能力并轻鬆地进行日常活动,同时提高他们的生活品质。因此,食物滴植入物在整个医疗保健行业中越来越受欢迎,用于恢復功能并促进患者更自然的步态。
由于神经损伤、运动相关损伤和道路事故的病例不断增加,足下垂的盛行率不断上升,这是支持市场成长的主要因素之一。此外,越来越多的老年人口更容易患上这种疾病,导致全球范围内对足下垂植入物的需求更高。此外,足下垂治疗已显着转向微创 (MI) 外科手术,因为它们恢復时间更短、疤痕和切口更少,并降低了併发症的风险。与此一致的是,越来越多地利用外科足下垂植入物来提供直接机械支撑和恢復肌肉功能,从而加快了产品的采用率。此外,领先的製造商正致力于推出新型植入物变体,以提供更好的稳定性、支撑、舒适性和易用性。此类产品创新正在改善患者的治疗效果和满意度,从而推动市场成长。除此之外,轻鬆获得有利的报销政策以及对个人化治疗方案不断增长的需求正在促进市场成长。其他因素,包括神经系统疾病发病率上升、医疗基础设施改善、医疗保健支出增加、植入物设计和材料的技术进步以及持续的研发 (R&D) 活动,预计也将推动未来几年的市场成长。
The global foot drop implants market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.46% during 2024-2032. The rising prevalence of foot drop and neurological disorders, expanding geriatric population, escalating demand for personalized treatment solutions, and technological advancements in implant design and materials represent some of the key factors driving the market.
Foot drop refers to a neurological disorder characterized by the dropping of the forefoot or difficulty in lifting the front part of the foot. It usually occurs due to damage to the common fibular nerve, weakness or paralysis of the muscles that control the ankle and foot movement, or injuries and conditions such as stroke, multiple sclerosis, and cerebral palsy. It can lead to difficulty or deviation from normal walking and is commonly associated with symptoms such as steppage gait and dorsiflexion. Foot drop implants are medical devices designed to reduce the functional limitations caused by this condition by replacing or reinforcing the damaged part. They provide stability and support to the ankle and foot, allowing patients to regain mobility and perform daily activities easily while improving the quality of their lives. As a result, food drop implants are gaining immense popularity across the healthcare industry for restoring function and facilitating a more natural gait in patients.
The rising prevalence of foot drop owing to the increasing cases of nerve damage, sports-related injuries, and road accidents represents one of the primary factors supporting the market growth. Moreover, the expanding geriatric population that is more susceptible to developing this condition is leading to a higher demand for foot drop implants across the globe. Additionally, there has been a significant shift toward minimally invasive (MI) surgical procedures for foot drop treatment as they offer a shorter recovery period, less scarring and incision, and reduced risk of complications. In line with this, the growing utilization of surgical foot drop implants to provide direct mechanical support and restore muscle function has accelerated product adoption rates. Furthermore, the leading manufacturers are focusing on the launch of novel implant variants that offer better stability, support, comfort, and ease of use. Such product innovations are improving patient outcomes and satisfaction, thereby propelling market growth. Besides this, the easy availability of favorable reimbursement policies and the escalating demand for personalized treatment options are augmenting market growth. Other factors, including the rising incidences of neurological disorders, improving medical infrastructure, increasing healthcare expenditure, technological advancements in implant design and materials, and ongoing research and development (R&D) activities, are also anticipated to fuel market growth in the coming years.
IMARC Group provides an analysis of the key trends in each segment of the global foot drop implants market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product and end user.
Functional Electrical Stimulators
Internal Fixation Devices
The report has provided a detailed breakup and analysis of the foot drop implants market based on the product. This includes functional electrical stimulators and internal fixation devices. According to the report, internal fixation devices represented the largest segment.
Hospitals
Palliative Care Centers
Orthopedic Centers
Others
A detailed breakup and analysis of the foot drop implants market based on the end user has also been provided in the report. This includes hospitals, palliative care centers, orthopedic centers, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for foot drop implants. Some of the factors driving the North America foot drop implants market included the growing burden of neurological conditions, rapidly aging population, continuous technological advancements and product launches by key players, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global foot drop implants market. Detailed profiles of all major companies have been provided. Some of the companies covered include aap Implantate AG, Acumed LLC (Colson Medical LLC), Arthrex Inc., Bioness Inc. (Bioventus Inc.), Narang Medical Limited, Ottobock SE & Co. KGaA, Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.